Search





Search





Markets
/
Stocks
/
bbot
/

BridgeBio Oncology Therapeutics Ord Shs

BBOT

Add to Watchlist

8.090USD

-0.410-4.82%

Close 07-31 16:00（ET）Quotes delayed by 15 min

648.07MMarket Cap

40.07P/E TTM

BridgeBio Oncology Therapeutics Ord Shs

8.090

-0.410-4.82%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-4.82%

5 Days

-8.28%

1 Month

-0.25%

6 Months

-32.75%

Year to Date

-35.38%

1 Year

-22.47%

Key Figures

8.500Open

8.590High

368.25KVolume

40.07P/E TTM

LossP/E Dynamic

--Dividend TTM

0.46%Turnover Ratio

8.500Prev. Close

8.010Low

2.08MTurnover

85.26P/E Static

1.74P/B

0.00%Div Yield TTM

2.44%ROA

14.87052wk High

1.30Volume Ratio

7.60MNet Profit

80.09MShares

0.2019EPS TTM

--Beta

2.53%ROE

7.60052wk Low

6.82%Amplitude

--Gross Margin

648.07MMarket Cap

0.25Reward/Risk

4.26%Risk Rate

BridgeBio Oncology Therapeutics Ord Shs News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 11 analysts

Buy

Current Rating

25.111

Target Price

+210.40%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

496

Total

Median

Average

Company name

Ratings

Analysts

BridgeBio Oncology Therapeutics Ord Shs

BBOT

Beigene Ltd

ONC

Ionis Pharmaceuticals Inc

IONS

argenx SE

ARGX

Kymera Therapeutics Inc

KYMR

Insmed Inc

INSM

...

Indicators

Indicators

Sell(3)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.123

Neutral

RSI(14)

45.231

Neutral

STOCH(KDJ)(9,3,3)

20.093

Sell

ATR(14)

0.550

Low Volatility

CCI(14)

-113.516

Sell

Williams %R

89.123

Oversold

TRIX(12,20)

0.296

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

8.433

Sell

MA10

8.574

Sell

MA20

8.575

Sell

MA50

8.214

Sell

MA100

8.510

Sell

MA200

10.131

Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

BridgeBio Oncology Therapeutics Ord Shs Info

Ticker Symbol

Company

CEO

Website

Shareholders

Shareholders

Proportion

Cormorant Asset Management, LP

22.32%

BridgeBio Pharma, Inc.

18.21%

Deerfield Management Company, L.P.

6.10%

BC Global Opportunities IX LP

5.45%

Omega Fund Management, LLC

4.11%

Other

43.81%

Popular Instruments

FAQs

What is the current price of BridgeBio Oncology Therapeutics Ord Shs (BBOT)?



The current price of BridgeBio Oncology Therapeutics Ord Shs (BBOT) is 8.09.

What is the symbol of BridgeBio Oncology Therapeutics Ord Shs?



The ticker symbol of BridgeBio Oncology Therapeutics Ord Shs is BBOT.

What is the 52-week high of BridgeBio Oncology Therapeutics Ord Shs?



The 52-week high of BridgeBio Oncology Therapeutics Ord Shs is 14.87.

What is the 52-week low of BridgeBio Oncology Therapeutics Ord Shs?



The 52-week low of BridgeBio Oncology Therapeutics Ord Shs is 7.60.

What is the market capitalization of BridgeBio Oncology Therapeutics Ord Shs?



The market capitalization of BridgeBio Oncology Therapeutics Ord Shs is 648.07M.

Is BridgeBio Oncology Therapeutics Ord Shs (BBOT) currently rated as Buy, Hold, or Sell?



According to analysts, BridgeBio Oncology Therapeutics Ord Shs (BBOT) has an overall rating of Buy, with a price target of 25.11.

What is the Earnings Per Share (EPS TTM) of BridgeBio Oncology Therapeutics Ord Shs (BBOT)?



The Earnings Per Share (EPS TTM) of BridgeBio Oncology Therapeutics Ord Shs (BBOT) is -4.30.